Free Trial
NASDAQ:CLPT

ClearPoint Neuro Q1 2025 Earnings Report

ClearPoint Neuro logo
$14.43 +0.52 (+3.74%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$14.39 -0.04 (-0.30%)
As of 05/2/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ClearPoint Neuro EPS Results

Actual EPS
N/A
Consensus EPS
-$0.15
Beat/Miss
N/A
One Year Ago EPS
N/A

ClearPoint Neuro Revenue Results

Actual Revenue
N/A
Expected Revenue
$8.21 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

ClearPoint Neuro Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
Tuesday, May 13, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

ClearPoint Neuro Earnings Headlines

Is he more powerful than Trump?
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
ClearPoint Neuro price target raised to $28 from $20 at B. Riley
See More ClearPoint Neuro Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ClearPoint Neuro? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ClearPoint Neuro and other key companies, straight to your email.

About ClearPoint Neuro

ClearPoint Neuro (NASDAQ:CLPT) operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

View ClearPoint Neuro Profile

More Earnings Resources from MarketBeat